CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials13919
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey12594
Breast cancer in a transgender man11340
Cancer treatment and survivorship statistics, 20256126
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies1986
1954
Issue Information1569
Near majority of adults favor R ratings for films with smoking644
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer502
Cancer statistics 2024: All hands on deck455
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians371
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies313
Most patients with cancer are not undergoing germline genetic testing310
Multicancer detection tests: What we know and what we don’t know282
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types276
Current treatment and future directions in the management of anal cancer248
More care needed for cancer caregivers241
212
Issue Information189
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine172
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review168
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians164
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach156
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial144
The evolving landscape of tissue‐agnostic therapies in precision oncology142
Health insurance status and cancer stage at diagnosis and survival in the United States138
Does distance deter male fertility preservation?107
Study identifies risk factors that may lead to secondary cancers103
Overlooked barriers to implementation of geriatric assessment89
Interventional gastroenterology in oncology82
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma80
Lung cancer screening guidelines: Smoking matters, not quitting79
Medicaid expansion increases survival for patients with cancer77
The contemporary management of cancers of the sinonasal tract in adults74
Issue Information73
Cancer survivors at greater risk for bone fractures late in life73
Screening for lung cancer70
Bilateral mastectomy may not reduce mortality risk69
Issue Information69
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance68
From medical student to Editor: A note of thanks67
Breast Cancer Statistics, 202263
Chemotherapy‐induced taste changes affect nutrition, quality of life58
Issue Information55
Prevention of device‐related infections in patients with cancer: Current practice and future horizons53
Clinical management of metastatic colorectal cancer in the era of precision medicine39
Cancer treatment and survivorship statistics, 202239
Better communication is key for quality‐of‐life improvement in low‐income and minority patients37
American Cancer Society nutrition and physical activity guideline for cancer survivors37
Issue Information35
35
33
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors32
Is active surveillance an alternative to surgery for some patients with esophageal cancer?32
Cancer misinformation on social media29
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries29
Key issues face AI deployment in cancer care27
26
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer25
Social determinants of health and US cancer screening interventions: A systematic review23
Radiotheranostics in oncology: Making precision medicine possible23
22
Urothelial carcinoma: Perioperative considerations from top to bottom22
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach21
Issue Information21
Geriatric assessment for the practicing clinician: The why, what, and how18
Global cancer statistics: A healthy population relies on population health17
Reviewer acknowledgement 202217
Is mandated genetic counseling needed?17
Smoking cessation support lags behind lung cancer screenings16
15
Carcinoma of unknown primary: Molecular tumor board‐based therapy15
Cancer statistics forAmericanIndian andAlaskaNative individuals, 2022: Including increasing disparities in early onset colorectal cancer15
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer14
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?14
13
Cancer disparities for LGBTQ+ patients identified more fully13
Issue Information12
Issue Information12
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer10
Sustained weight loss may reduce cancer risk10
The evolving landscape of salivary gland tumors10
Issue Information10
Study identifies signs and symptoms of colorectal cancer risk at younger ages10
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer9
Genomic‐derived radiation dosage improves prediction of outcomes9
New studies examine COVID‐19 risks among cancer patients9
Issue Information7
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates7
Virtual exercise regimens can help patients with cancer7
An overview of real‐world data sources for oncology and considerations for research7
American Cancer Society's report on the status of cancer disparities in the United States, 20217
6
6
Update and new advances in fertility preservation and cancer5
5
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review5
Modern developments in germline pharmacogenomics for oncology prescribing5
Issue Information4
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians4
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management4
Erratum to “Cancer statistics, 2024”4
How can hospitals change practice to better implement smoking cessation interventions? A systematic review4
Erectile dysfunction common within the first year after rectal cancer surgery4
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy4
Locally advanced lung cancer4
Cancer statistics for African American and Black people, 20253
Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology3
MCED blood test boosts cancer detection in symptomatic patients3
Colon cancer blood test effective for average‐risk population3
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature3
Issue Information3
Cancer in rural America: Improving access to clinical trials and quality of oncologic care3
3
3
0.035112857818604